202. Smith-Magenis syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 9 /  Drugs : 10 - (DrugBank : 5) / Drug target genes : 4 - Drug target pathways : 7

Smith-Magenis syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
202Smith-Magenis syndrome
37Generalised pustular psoriasis
49Systemic lupus erythematosus
97Ulcerative colitis
46Malignant rheumatoid arthritis
6Parkinson disease
13Multiple sclerosis/Neuromyelitis optica
149Hemiconvulsion hemiplegia epilepsy syndrome
145West syndrome
90Retinitis pigmentosa
144Lennox-Gastaut syndrome
8Huntington disease